The role of hyperoxia in the pathogenesis of experimental BPD
- PMID: 23582960
- PMCID: PMC3627182
- DOI: 10.1053/j.semperi.2013.01.002
The role of hyperoxia in the pathogenesis of experimental BPD
Abstract
Supplemental oxygen is often used as a life-saving therapy in the treatment of preterm infants. However, its protracted use can lead to the development of bronchopulmonary dysplasia (BPD), and more recently, has been associated with adversely affecting the general health of children and adolescents who were born preterm. Efforts to understand how exposure to excess oxygen can disrupt lung development have historically focused on the interplay between oxidative stress and antioxidant defense mechanisms. However, there has been a growing appreciation for how changes in gene-environment interactions occurring during critically important periods of organ development can profoundly affect human health and disease later in life. Here, we review the concept that oxygen is an environmental stressor that may play an important role at birth to control normal lung development via its interactions with genes and cells. Understanding how changes in the oxygen environment have the potential to alter the developmental programing of the lung, such that it now proceeds along a different developmental trajectory, could lead to novel therapies in the prevention and treatment of respiratory diseases, such as BPD.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures


References
-
- Howson CP, Kinney MV, Lawn JE, editors. March of Dimes P, Save the Children, WHO. Born Too Soon: The Global Action Report on Preterm Birth. World Health Organization; Geneva: 2012.
-
- Smith VC, Zupancic JA, McCormick MC, Croen LA, Greene J, Escobar GJ, et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr. 2004 Jun;144(6):799–803. - PubMed
-
- Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001 Jun;163(7):1723–9. - PubMed
-
- Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007 Nov 8;357(19):1946–55. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 HL067392/HL/NHLBI NIH HHS/United States
- HL-091968/HL/NHLBI NIH HHS/United States
- T32 HD057821/HD/NICHD NIH HHS/United States
- HL-097141/HL/NHLBI NIH HHS/United States
- R01 ES007026/ES/NIEHS NIH HHS/United States
- R01 HL091968/HL/NHLBI NIH HHS/United States
- ES-07026/ES/NIEHS NIH HHS/United States
- R01 HL097141/HL/NHLBI NIH HHS/United States
- HD-057821/HD/NICHD NIH HHS/United States
- HL-66988/HL/NHLBI NIH HHS/United States
- T32 ES007026/ES/NIEHS NIH HHS/United States
- HL-067392/HL/NHLBI NIH HHS/United States
- T32 HL066988/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical